Susanne Schaffert - Net Worth and Insider Trading

Susanne Schaffert Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Susanne Schaffert owns 2 companies in total, including Rubius Therapeutics Inc (RUBY) , and Incyte Corp (INCY) .

Click here to see the complete history of Susanne Schaffert’s form 4 insider trades.

Insider Ownership Summary of Susanne Schaffert

Ticker Comapny Transaction Date Type of Owner
RUBY Rubius Therapeutics Inc 2022-07-12 director
INCY Incyte Corp 2022-10-01 director

Susanne Schaffert Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Susanne Schaffert Ownership Network

Ownership Network List of Susanne Schaffert

No Data

Ownership Network Relation of Susanne Schaffert

Susanne Schaffert Owned Company Details

What does Rubius Therapeutics Inc do?

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Who are the key executives at Rubius Therapeutics Inc?

Susanne Schaffert is the director of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , 10 percent owner Flagship Ventures Fund V General Partner Llc , and 10 percent owner Flagship Ventures Opportunities Fund I General Partner Llc .

Rubius Therapeutics Inc (RUBY) Insider Trades Summary

Over the past 18 months, Susanne Schaffert made no insider transaction in Rubius Therapeutics Inc (RUBY). Other recent insider transactions involving Rubius Therapeutics Inc (RUBY) include a net sale of 22,418 shares made by Pablo J Cagnoni , a net sale of 20,000 shares made by Dannielle Appelhans , and a net sale of 5,110 shares made by Laurence A. Turka .

In summary, during the past 3 months, insiders sold 32,544 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 32,544 shares. During the past 18 months, 50,260 shares of Rubius Therapeutics Inc (RUBY) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 20,260 shares.

Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.


Rubius Therapeutics Inc Insider Transactions

Total 0
Shares Owned
Trade Price($)
Trade Percentage(%)
Price change since trade(%)
Share ownership details
Filing Date
Total 0

Susanne Schaffert Mailing Address

Above is the net worth, insider trading, and ownership report for Susanne Schaffert. You might contact Susanne Schaffert via mailing address: C/o Rubius Therapeutics, Inc., 399 Binney Street, Suite 300, Cambridge Ma 02139.